Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page
It was a great company, driven into the ground by ex-Merck and ex-Novartians who joined thinking only of the $$$ they would earn whilst stepping on everyone they could to seek favor with their managers.
Novartians are the worst anywhere, especially those from legal. We had a machine humming until all the female legal Novartians showed up looking not to help, but to hurt sales while disguising their efforts are helpful.
Couple big, mean female lawyers caused a bunch of problems. I know one was a Novartin for sure. Then there was the compliance woman who was going to law school at night. She actually knew what we did for a living, but she was way out of touch on how lunches actually work. These BMY lawyers at least understand that we feed the whole office, and only sell to the providers.